We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+6.11%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$3.25B
AUM Growth
+$233M
Cap. Flow
+$71.7M
Cap. Flow %
2.21%
Top 10 Hldgs %
43.43%
Holding
357
New
26
Increased
176
Reduced
122
Closed
12
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPAY icon
351
Amplify Mobile Payments ETF
IPAY
$186M
-80,690
Closed -$3.74M
LIT icon
352
Global X Lithium & Battery Tech ETF
LIT
$1.55B
-23,711
Closed -$1.21M
MUB icon
353
iShares National Muni Bond ETF
MUB
$45.4B
-2,338
Closed -$253K
OTLK icon
354
Outlook Therapeutics
OTLK
$180M
-500
Closed -$3.94K
PNNT
355
Pennant Park Investment Corp
PNNT
$230M
-24,380
Closed -$168K
VTRS icon
356
Viatris
VTRS
$20.6B
-10,174
Closed -$110K
XBI icon
357
State Street SPDR S&P Biotech ETF
XBI
$9.92B
-60,750
Closed -$5.42M

Similar funds

Grimes & Company's Q1 2024 Portfolio in Review

As of Q1 2024, Grimes & Company held 357 positions worth $3.25B, up 7.7% from $3.02B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Grimes & Company's Q1 2024 filing shows 26 new, 176 increased, 122 reduced and 12 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 352,196 shares worth $14.8M. The largest sale was State Street Energy Select Sector SPDR ETF, an estimated $17.9M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Grimes & Company's largest Q1 2024 buy was State Street Financial Select Sector SPDR ETF: 352,196 shares worth $14.8M.
  • Grimes & Company added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2024, an estimated $27.8M increase.
  • Grimes & Company's biggest Q1 2024 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $17.9M.
  • Grimes & Company fully exited State Street SPDR S&P Biotech ETF in Q1 2024, selling an estimated $5.42M.
  • Grimes & Company's ten largest holdings make up 43% of its $3.25B portfolio in Q1 2024.
  • Grimes & Company opened 26 new positions and closed 12 in Q1 2024.
  • Grimes & Company's portfolio value rose 7.7% quarter-over-quarter to $3.25B.

Based on Grimes & Company's 13F filing for Q1 2024, filed 17 Apr 2024.